Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 17, 2022
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
Hartaj Singh Maintained (SPRB) at Buy with Decreased Target to $8 on, Nov 17th, 2022
Hartaj Singh of Oppenheimer, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $13 to $8 on, Nov 17th, 2022.
Hartaj has made no other calls on SPRB in the last 4 months.
There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Hartaj's Rating of Hold.
This is the rating of the analyst that currently disagrees with Hartaj
- Jonathan Wolleben of "JMP Securities" Initiated at Buy and Held Target at $8 on, Wednesday, November 16th, 2022
